Background. Sexually transmitted bacterial rectal infections are objective markers of HIV risk behavior. Quantifying HIV risk among men who have sex with men (MSM) who have had these infections can inform prevention efforts. We measured HIV risk among MSM who have and those who have not been diagnosed with rectal Chlamydia trachomatis (CT) and/or rectal Neisseria gonorrhoeae (GC).
and maximize use of data for public health action. In 2010, New York State enacted regulatory changes that enhanced the ability of HIV surveillance programs to share data on reported cases with other disease programs within its state or local health departments [14] . Specifically, patient identifiers can be shared to assess comorbidity and completeness of reporting or to meet program needs.
Rectal infections with bacterial STD can indicate unprotected anal intercourse, a risk factor for HIV acquisition [11, 15] . To estimate HIV incidence among MSM reporting anal intercourse, and the additional risk of HIV among those diagnosed with a rectal STD, we measured HIV incidence following infection with rectal Chlamydia trachomatis (CT) and/or GC (CT/ GC) among a clinic-based cohort of HIV-negative MSM, and among a clinic-based sample of HIV-negative MSM without rectal CT/GC. For MSM who had rectal CT/GC, we identified risk factors for HIV acquisition. We matched both groups against the citywide HIV surveillance registry, which enabled us to quantify the added value of matching to ascertain all incident HIV infections over using only cases diagnosed in the NYC STD clinic system.
METHODS
All persons attending NYC public STD clinics are offered HIV testing with a rapid point-of-care HIV antibody test, and asked whether they have had receptive anal intercourse (RAI) in the prior 3 months. MSM whose rapid HIV tests are negative have further testing done using a pooled HIV-1 nucleic acid amplification test (NAAT). Persons reporting RAI are offered rectal testing using GC culture and CT NAAT.
HIV Incidence Among MSM With Rectal STDs
We constructed a retrospective cohort of all MSM diagnosed with rectal CT, rectal GC, or both at NYC STD clinics from 1 January 2008 through 31 March 2010 who tested HIV-negative by NAAT at the same visit (ie, confirmed HIV-negative). Men with multiple rectal infections diagnosed during this period entered the cohort at the time of their last diagnosis.
The outcome of interest was time from rectal infection to HIV diagnosis; we conducted survival analysis to account for varying times to HIV diagnosis. For MSM with rectal CT/GC who acquired HIV, HIV-free time at risk was the interval between rectal test collection date and HIV diagnosis date; those not reported with HIV were classified as uninfected during the analytic period and were censored on 31 March 2011 to allow all at least 1 year of follow-up. To ascertain all newly diagnosed HIV infections, including those diagnosed outside STD clinics, in May 2011 we matched the cohort against the HIV surveillance registry with an automated matching algorithm that uses up to 36 combinations of available patient information (eg, name, date of birth, social security number) to identify confirmed and probable matches. Probable matches were manually reviewed.
Factors Associated With HIV Acquisition Among MSM With Rectal CT/GC
For MSM with rectal infections, Cox proportional hazards models were used to explore associations between HIV diagnosis and demographic and behavioral characteristics that are routinely collected during clinic visits. Covariates included rectal STD diagnosis at cohort entry (CT, GC, or both) and age at that diagnosis, race/ethnicity, early syphilis diagnosis (concurrently or in the past 2 years as documented in the citywide STD surveillance registry), and reported number of sex partners and consistency of condom use with receptive anal sex (always, sometimes, never) in the 3 months prior to CT/GC diagnosis.
HIV Incidence Among MSM Without Rectal CT/GC
To estimate HIV risk among MSM without rectal CT/GC, we created a sample of 276 MSM (equal to the number with rectal infections) from among MSM who reported RAI, were tested for rectal CT, rectal GC, and HIV (as described above) at the same visit between 1 January 2008 and 31 March 2010, and tested negative for all 3 infections. MSM with any previous rectal CT/GC documented in STD clinic records were excluded from the sample.
We selected MSM without rectal CT/GC to be demographically and behaviorally similar to MSM with these infections; they were individually matched on age (within 5 years), race/ ethnicity, reported number of sex partners in the past 3 months, and history of early syphilis. For men with ≥1 visit at which all 3 tests were negative during this time period, followup for HIV started at the time of their last such visit. Acquisition of HIV was ascertained in the same manner as for MSM with rectal infections. Kaplan-Meier survival estimates of time to HIV diagnosis were examined. We used the McNemar test to account for pairwise matching in the comparison of HIV outcomes among MSM with and those without rectal infections.
HIV testing is voluntary; therefore, MSM were not required to take an HIV test during the follow-up period. In NYC STD clinics, the standard of care is to offer a test to all HIV-negative patients who have not been tested for HIV in the previous 3 months, and to patients suspected of acute HIV infection. To assess the extent to which MSM in the study were repeatedly tested for HIV, we calculated the proportion of all patients who were not reported with HIV during follow-up that had repeat negative HIV tests in the NYC STD clinics during the period. We could not account for patients who tested for HIV in non-STD clinic settings and had only negative results, as negative tests are not reportable to any surveillance registry.
Analyses were conducted using Intercooled Stata 7.0 (Stata Corp, College Station, Texas). After STD-HIV matching was performed, all analyses were conducted on deidentified records. The study was determined to be exempt research by the NYC Department of Health and Mental Hygiene Institutional Review Board.
RESULTS
During January 2008-March 2010, there were 3370 visits made by MSM that included a negative HIV pooled NAAT result. Among these visits, 2345 rectal CT and 2391 rectal GC tests were performed. Rectal CT positivity was 9.6% (226/2345 tests) and rectal GC positivity was 4.6% (109/2391 tests). Eighty-five percent (192/226) of rectal CT and 72% (78/109) of rectal GC infections were asymptomatic. Ninety-eight percent of MSM with rectal CT/GC were treated at the STD clinics within 60 days of their positive test(s).
All 276 HIV-negative MSM with diagnosed rectal CT (n = 177), rectal GC (n = 69), or both (n = 30) comprised the analytic cohort. Eleven (5.1%) had multiple rectal infections during the period (9 had 2 diagnoses, and 2 had 3 diagnoses). Of the 276 MSM, 69.6% (190/273) reported no or occasional condom use during anal sex and a mean of 3.5 sex partners (range, 1-30) in the previous 3 months. Altogether, they contributed 464.7 person-years of follow-up (median followup, 1.63 years; range, 0.27-3.21 years). Of the cohort, 11.2% (31/276) were diagnosed and reported with HIV during followup, yielding an annual HIV incidence of 6.67% (95% confidence interval [CI], 4.61%-9.35%; Table 1 ). Among those acquiring HIV, 17 (55%) were diagnosed with HIV in STD clinics and an additional 14 (45%) were diagnosed by other providers and identified only by matching against the HIV registry. The median time from rectal infection diagnosis to HIV diagnosis was 309 days (interquartile range, 224-564 days).
HIV incidence was particularly high among certain subgroups with rectal infections: black MSM, 15.34% (95% CI, 8.31%-26.08%); MSM with both CT and GC, 10.67% (95% CI, 3.91%-23.66%); and MSM aged <20 years, 10.46% (95% CI, 3.83%-23.19%) ( Table 1 ). In univariate regression analysis, race/ethnicity was the only characteristic associated with an increased risk of HIV; black MSM with rectal CT/GC were 5 times as likely to acquire HIV than white MSM with rectal CT/ GC (hazard ratio, 4.98; 95% CI, 1.75-14.17; Table 2 ).
The comparison group of 276 MSM without diagnosed rectal CT/ GC was selected from among 1757 MSM who reported RAI and tested negative for rectal CT, rectal GC, and HIV at the same visit from 1 January 2008 through 31 March 2010. As a result of the matching scheme, this group was similar to MSM with rectal CT/GC with regard to age, race/ ethnicity, prevalence of early syphilis history (13% vs 10%, P = .24), no or occasional condom use during anal sex (69.6% vs 68.6%), and reported number of partners in the past 3 months (mean, 3.5 vs 3.4). The comparison group contributed 473.8 person-years of follow-up; 12 (4.3%) were diagnosed and reported with HIV (STD clinics: 6, other providers: 6), for an annual HIV incidence of 2.53% (95% CI, 1.31%-4.42%; Table 3 ). Having had rectal CT/GC was associated with an increased risk of HIV infection (Figure 1 ). MSM with rectal infections were significantly more likely to be diagnosed with HIV (relative risk, 2.58; 95% CI, 1.33-5.03) compared to MSM without rectal infections. STD clinic record reviews showed that 232 (45.6%) of the 509 MSM categorized as HIV negative had at least 1 more HIV test in STD clinics during the follow-up period; the proportion with repeat tests did not vary by rectal CT/GC status. Additionally, of all 20 MSM diagnosed with HIV at non-STD clinic sites, 7 (35%) had documented negative tests in STD clinics during their HIV-free time at risk.
DISCUSSION
HIV incidence rates in our study were high, and significantly elevated among MSM with a history of rectal infections, with 1 in 15 of them being diagnosed with HIV within only a year. Among those with rectal infections, incidence was highest among young MSM and black MSM, subgroups that are disproportionately affected by HIV in NYC [4, 16] and have the largest increases in rates of new infections nationally [17] . Cross-matching patients with STD against the HIV registry markedly improved our ascertainment of incident HIV by identifying almost double the diagnoses that would have been identified using STD clinic records alone. Our findings have implications for medical care, prevention interventions, and the sharing of public health surveillance data.
Unprotected anal intercourse carries a risk for HIV acquisition, and it is commonly reported among the general population of NYC MSM, with only 41% reporting always using a condom during anal sex [18] . Although HIV acquisition also depends on the HIV prevalence in sexual networks from which MSM select partners, findings from 2 large prospective cohorts showed that at least 1 unprotected RAI act in 6 months was associated with high seroconversion rates over 3-4 years (2.5% in one cohort and 5.3% in the other). In that study, unprotected RAI constituted the most impactful score on a screening index that could be used by clinicians to determine which MSM patients are at highest risk of acquiring HIV [19] . In our study, on an annual basis, 2.5% of MSM reporting RAI but without rectal CT/GC acquired HIV, and almost 7% of MSM who had acquired 1 or both infections were subsequently diagnosed with HIV. MSM with concurrent rectal CT and GC had a particularly high annual HIV incidence. Our results demonstrate that rectal CT/GC infections are objective markers for identifying persons at an exceptionally high risk for HIV.
We found that most bacterial rectal infections (>70%) were asymptomatic, underscoring the need for routine rectal screening of patients who report unprotected anal intercourse. To provide appropriate care, providers must take a nonjudgmental and confidential sexual history that ascertains the sex of a patient's sex partners and anatomic sites of sexual exposure; however, this is often not done [20] . There are other recognized barriers to STD care, including providers' lack of time and insufficient staff to address STDs, counsel patients, and follow up with sex partners [21] . These barriers may have an increased impact on STD diagnoses in coming years, as public STD clinics are closing or their services are being reduced [22] and provision of services is shifting into general practice and urgent care centers. Another substantial barrier to optimal care is that no CT and GC NAATs have been approved by the US Food and Drug Administration for use on oral and rectal specimens. Extragenital CT and GC NAATs, favorable tests due to short turnaround times for results and high sensitivity and specificity, are available through a limited number of laboratories that have performed verification studies of NAATs for extragenital specimens. These tests must be made widely available to improve the quality of health care for MSM. Patient encounters that include STD testing, diagnosis, and treatment are opportune times to educate patients about the risk for HIV acquisition and, ideally, to intervene to decrease risk. Our findings support the continuing need for counseling around condom use and reducing numbers of sex partners. Our results also point to using rectal CT/GC infection as a possible criterion for recommending HIV preexposure chemoprophylaxis (PrEP). Following the publication of a recent clinical trial that showed a reduction in HIV incidence of 44% among MSM on daily tenofovir-emtricitabine therapy (and 73% for MSM with high adherence) [23] , the US Centers for Disease Control and Prevention (CDC) published interim guidance for using it as PrEP for MSM [24] . A number of cost-effectiveness studies have shown that PrEP use by MSM at high risk of HIV acquisition could have a substantial impact on the US HIV epidemic [25] [26] [27] . Our findings may be useful to clinicians and policymakers considering how to target PrEP. MSM who have been diagnosed with rectal CT/GC are at an extremely high risk and would be a group to consider. Additionally, given the substantial HIV incidence we measured among MSM without these infections, a recommendation for PrEP could be expanded to all MSM reporting RAI in settings serving populations with high HIV detection rates, such as STD clinics.
Matching clinic-based STD case data with HIV registry case data yielded fully 80% more HIV diagnoses compared to the number that would have been identified through STD clinic records alone. Our overall HIV incidence among MSM with rectal CT/GC was almost 3 times the incidence found in a San Francisco study [15] , in which subsequent HIV diagnoses were ascertained through STD clinic records or via self-report. The CDC has recently recommended common standards for securing and protecting HIV, viral hepatitis, STD, and tuberculosis surveillance data, which should facilitate data sharing, collaboration, and service integration among funded programs [28] . STD/HIV data matching and integration permit more accurate incidence estimates and definition of affected populations for informing STD/HIV prevention activities, especially in areas such as NYC, where there are many different provider practices and testing sites where HIV can be diagnosed, and the majority of diagnoses citywide (approximately 85%) occur in non-STD clinic settings. There are limitations to our analysis. First, our outcome of interest was diagnosed HIV infection, and as with other observational studies, some MSM may not have had an HIV test during the follow-up period; this could have resulted in a lack of detection and an underestimate of true HIV incidence. However, we found that a substantial proportion of MSM categorized as negative had additional tests in our clinics during follow-up. Furthermore, one-third of the MSM who eventually tested positive at non-STD clinics also had documented negative tests at the STD clinics, which suggests that our population tests for HIV at a variety of venues. Hence, it is likely that the majority of HIV infections were diagnosed. Second, rectal CT/ GC diagnoses were identified only from STD clinic records; we did not use the STD surveillance registry of all CT and GC diagnosed by NYC providers due to the incompleteness of anatomic site of specimen collection on provider and laboratory reports in the registry. Thus, we may have missed counting rectal infections diagnosed by non-STD clinic providers. For MSM with rectal infections diagnosed in STD clinics who may have had subsequent rectal infections diagnosed elsewhere, not starting their follow-up time at the time of the last infection may have (1) overestimated their time at risk for HIV and (2) underestimated the cohort's true HIV incidence. For MSM in the CT/GC-negative comparison group, failure to count diagnoses by non-STD clinic providers could have resulted in their erroneous assignment to the CT/GC-negative group, and an overestimation of HIV risk among persons without rectal CT/ GC. Third, rectal GC was diagnosed by culture; given the lower sensitivity of culture compared to NAAT, some GC infections may have been missed. Fourth, for MSM with multiple rectal infections, using the date of their last instead of first diagnosis shortened their HIV-free time at risk. However, only 5% had multiple rectal infections, and counting their last one would not have appreciably reduced the aggregate follow-up time or estimate of HIV incidence for the cohort. Finally, HIV incidence rates and predictors of HIV among STD clinic patients may not be generalizable to other patient populations. Visits to STD clinics are typically prompted by patient recognition of high-risk behaviors [29] and result in a high yield of HIV and other STD diagnoses. However, we believe that our finding of an elevated risk of HIV infection among those who have had rectal CT/GC infections may apply to many other settings, given the high per-act probability of HIV infection with RAI [30] and host inflammatory responses and alterations in immune defenses that occur with STDs [31] .
With the HIV/AIDS epidemic in its third decade and the prospect of effective HIV vaccines as yet unrealized, it remains important to focus on developing and applying new HIV prevention strategies. Identifying and treating rectal infections may reduce HIV incidence, to the extent that rectal STDs increase biological susceptibility to HIV infection through epithelial erosions and alteration of host immune defenses. Furthermore, rectal infections, as markers of behavioral risk, can be used to identify a subset of patients who may benefit from intensive risk reduction counseling and other interventions designed to reduce the risk of HIV transmission.
Notes

